Deciphering generic drug names using the World Health Organization international nonproprietary names system Drugs have several types of names, as described in How are drugs named. Briefly, a drug’s tradename (E.g.…
The post A Comprehensive…
Generic competitors change things significantly for brand name pharmaceutical manufacturers In pharmaceuticals, drug patents and exclusivity are similar, but not identical. Drug patents are intellectual property rights conferred by the US…
The post Acc…
Accurate Forecasting of Product Returns Essential to Pharmaceutical Financial Fitness Read Post »
Biosimilars are expected to bring down costs of innovative treatments for conditions like cancer and autoimmune diseases “Biologics” are some of today’s most promising medications. Unlike “small molecule drugs” (such…
The post Predicting Patent L…
Predicting Patent Litigation Outcomes for Biosimilars Read Post »
Are protections in place to prevent bribing of FDA officials? With drugs such as Lipitor achieving lifetime sales well over $100 billion, the motivation to use any means available to…
The post Can Drug Companies Bribe the FDA? appeared first on D…
IT and software technologies attract the most patent lawsuits, but pharmaceuticals are targeted too In the US, patent infringement cases nearly doubled from the year 2010 to 2014. Sixty-one percent…
The post 5 Ways to Predict Patent Litigation Ou…
Patent linkage refers to the relationship between the market approval of a generic drug and the patent status of its branded equivalent. It dictates that marketing approval for a generic…
The post Patent linkage: Balancing patent protection and generic…
Patent linkage: Balancing patent protection and generic entry Read Post »
What are generic drugs? A generic drug is an identical, or bioequivalent, version of a branded drug made by another party. For approval of a generic, the drug company must…
The post Are Generic Drugs Less Safe than their Branded Equivalents? appeared f…
Are Generic Drugs Less Safe than their Branded Equivalents? Read Post »
… the very first official thing I did, in my administration … was to start a patent office; for I knew that a country without a patent office and good…
The post A Brief Patent Primer appeared first on DrugPatentWatch – Make Better Decisions.
Drug patent intelligence can prepare pharmacists and prescribers for new, less expensive alternatives The National Conference of State Legislatures (NCSL) has been researching and providing guidance to states on medical…
The post How Drug Patent Intell…
How Drug Patent Intelligence Facilitates Cost Containment Read Post »
Generic drugs present an opportunity for drug companies to generate substantial revenues. But where do companies find the best return for their investment of time and money? With mature markets…
The post Finding Generic Drug Entry Opportunities in Emer…
Finding Generic Drug Entry Opportunities in Emerging Markets Read Post »